Safety and efficacy of a novel AAV vector for treatment of hemophilia B

被引：0
|
作者：
Anguela, X. [1 ,2 ]
Toso, R. [2 ]
Couto, L. B. [2 ]
Chen, Y. [2 ]
Hui, D. [2 ]
DiPietro, M. [2 ]
Lee, B. [1 ]
Qu, G. [2 ]
Hauck, B. [2 ]
Corbau, R. [1 ,2 ]
Wright, F. [2 ]
High, K. A. [2 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Spark Therapeut Inc, Philadelphia, PA USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO172-MON
引用
收藏
页码：324 / 325
页数：2
相关论文
共 50 条
  • [21] Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia
    Hauck, B
    Xu, RR
    Xie, J
    Wu, WM
    Ding, QL
    Sipler, M
    Wang, HL
    Chen, L
    Wright, JF
    Xiao, WD
    HUMAN GENE THERAPY, 2006, 17 (01) : 46 - 54
  • [22] AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects
    Hasbrouck, N. C.
    High, K. A.
    GENE THERAPY, 2008, 15 (11) : 870 - 875
  • [23] AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects
    N C Hasbrouck
    K A High
    Gene Therapy, 2008, 15 : 870 - 875
  • [24] AAV vectors for hemophilia B gene therapy
    Chao, HJ
    Walsh, CE
    MOUNT SINAI JOURNAL OF MEDICINE, 2004, 71 (05): : 305 - 313
  • [25] Development of a Synthetic AAV Vector for Gene Therapy of Hemophilia in Children
    Shoti, Jakob
    Qing, Keyun
    Srivastava, Arun
    MOLECULAR THERAPY, 2022, 30 (04) : 332 - 332
  • [26] Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
    Haurigot, Virginia
    Mingozzi, Federico
    Buchlis, George
    Hui, Daniel J.
    Chen, Yifeng
    Basner-Tschakarjan, Etiena
    Arruda, Valder R.
    Radu, Antoneta
    Franck, Helen G.
    Wright, J. Fraser
    Zhou, Shangzhen
    Stedman, Hansell H.
    Bellinger, Dwight A.
    Nichols, Timothy C.
    High, Katherine A.
    MOLECULAR THERAPY, 2010, 18 (07) : 1318 - 1329
  • [27] Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
    Shapiro, Amy D.
    Angchaisuksiri, Pantep
    Astermark, Jan
    Benson, Gary
    Castaman, Giancarlo
    Eichler, Hermann
    Jimenez-Yuste, Victor
    Kavakli, Kaan
    Matsushita, Tadashi
    Poulsen, Lone Hvitfeldt
    Wheeler, Allison P.
    Young, Guy
    Zupancic-Salek, Silva
    Oldenburg, Johannes
    Chowdary, Pratima
    BLOOD ADVANCES, 2022, 6 (11) : 3422 - 3432
  • [28] Safety and Efficacy of Liver-Directed AAV Gene Therapy in Privately Owned Dogs with Severe Hemophilia A
    Van Gorder, Lucas
    Doshi, Bhavya S.
    Willis, Elinor
    Nichols, Timothy C.
    Lanza, Matthew
    Cook, Emma
    Everett, John
    Merricks, Elizabeth
    Arruda, Valder R.
    Bushman, Frederic
    Samelson-Jones, Benjamin
    Callan, Mary Beth
    MOLECULAR THERAPY, 2023, 31 (04) : 315 - 316
  • [29] Improved efficacy in gene therapy of hemophilia A using an AAV6 pseudo-typed FVIII vector
    Jiang, HY
    Patarroyo-White, S
    Nagy, D
    Vargas, J
    Scallan, C
    Liu, TY
    Powell, S
    Wright, F
    Couto, L
    MOLECULAR THERAPY, 2003, 7 (05) : S184 - S184
  • [30] Hemophilia A Dogs Tolerant to Human Factor VIII Provide a Unique Model to Determine Efficacy and Safety of AAV Delivery of Novel Factor VIII Variants
    Nguyen, Giang N.
    Wimsey, Lauren E.
    Merricks, Elizabeth P.
    Ponder, Katherine P.
    Nichols, Timothy C.
    Sabatino, Denise E.
    BLOOD, 2019, 134
12345